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ABSTRACT Trichomonas vaginalis is a highly prevalent, sexually transmitted parasite
which adheres to mucosal epithelial cells to colonize the human urogenital tract.
Despite adherence being crucial for this extracellular parasite to thrive within the host,
relatively little is known about the mechanisms or key molecules involved in this pro-
cess. Here, we have identified and characterized a T. vaginalis hypothetical protein,
TVAG_157210 (TvAD1), as a surface protein that plays an integral role in parasite adher-
ence to the host. Quantitative proteomics revealed TvAD1 to be ;4-fold more abun-
dant in parasites selected for increased adherence (MA parasites) than the isogenic
parental (P) parasite line. De novo modeling suggested that TvAD1 binds N-ace-
tylglucosamine (GlcNAc), a sugar comprising host glycosaminoglycans (GAGs). Adherence
assays utilizing GAG-deficient cell lines determined that host GAGs, primarily heparan sul-
fate (HS), mediate adherence of MA parasites to host cells. TvAD1 knockout (KO) parasites,
generated using CRISPR-Cas9, were found to be significantly reduced in host cell adher-
ence, a phenotype that is rescued by overexpression of TvAD1 in KO parasites. In contrast,
there was no significant difference in parasite adherence to GAG-deficient lines by KO par-
asites compared with wild-type, which is contrary to that observed for KO parasites overex-
pressing TvAD1. Isothermal titration calorimetric (ITC) analysis showed that TvAD1 binds to
HS, indicating that TvAD1 mediates host cell adherence via HS interaction. In addition to
characterizing the role of TvAD1 in parasite adherence, these studies reveal a role for host
GAG molecules in T. vaginalis adherence.
IMPORTANCE The ability of the sexually transmitted parasite Trichomonas vaginalis to
adhere to its human host is critical for establishing and maintaining an infection. Yet
how parasites adhere to host cells is poorly understood. In this study, we employed
a novel adherence selection method to identify proteins involved in parasite adher-
ence to the host. This method led to the identification of a protein, with no previ-
ously known function, that is more abundant in parasites with increased capacity to
bind host cells. Bioinformatic modeling and biochemical analyses revealed that this pro-
tein binds a common component on the host cell surface proteoglycans. Subsequent
creation of parasites that lack this protein directly demonstrated that the protein medi-
ates parasite adherence via an interaction with host cell proteoglycans. These findings
both demonstrate a role for this protein in T. vaginalis adherence to the host and shed
light on host cell molecules that participate in parasite colonization.
KEYWORDS Trichomonas vaginalis, adherence, proteomics, glycosaminoglycans,
heparan sulfate, host-pathogen interactions
T richomonas vaginalis is a flagellated, eukaryotic parasite and the etiologic agent oftrichomoniasis, the most common nonviral sexually transmitted infection worldwide.
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The global burden of T. vaginalis infections is high, with reports of roughly 156 million
new cases worldwide and over 276 million cases annually (1, 2). In the United States, an
estimated 3.7 million people are currently infected with T. vaginalis (3, 4). Although T. vagi-
nalis infections are primarily asymptomatic, trichomoniasis symptoms can include vaginitis,
prostatitis, urethritis, discharge, infertility, and adverse pregnancy outcomes, such as pre-
term delivery and low birth weight in infants (5–7). Additionally, T. vaginalis has been asso-
ciated with increased acquisition of HIV (8–11) and increased risk of cervical and prostatic
cancers (12–15). While there are serious consequences attributed to trichomoniasis, the
underlying processes of T. vaginalis pathogenesis remain poorly defined.
As T. vaginalis is an extracellular organism, its adherence to host mucosal tissues is
critical for parasite survival. Attachment to the urogenital epithelium of men and
women by the parasite allows for the establishment and maintenance of an infection
as well as nutrient acquisition from host cells (16, 17). The adherence ability of T. vagi-
nalis to host cells in vitro is strain dependent, exhibiting up to a 45-fold difference in
adherence ability between strains (18). In silico analysis of the T. vaginalis genome iden-
tified .5,100 proteins carrying 1 or more transmembrane domains and over 300 anno-
tated proteins from across 10 protein families with a predicted contribution to coloni-
zation and parasite cytopathogenicity (19, 20). Furthermore, studies into the molecular
mechanisms of T. vaginalis attachment to the host mucosal tissues suggest that para-
site adherence to the host is multifaceted with many factors yet to be defined (16,
21–25).
Due to the vast number of surface proteins potentially involved in parasite adher-
ence to the host, the surface membrane proteomes of 3 adherent and 3 lowly adherent
T. vaginalis strains were compared (26). This study identified 271 putative plasma mem-
brane proteins with 11 of them found to be significantly more abundant in the adher-
ent strains than in the lowly adherent strains. Following this work, a number of these
putative surface proteins were further characterized as parasite adherence proteins
(27–29), further validating this approach. However, the ability to strictly correlate the
presence and abundance of specific proteins to the adherence phenotype in this study
was limited by the high level of variability exhibited by the different T. vaginalis isolates.
Here, we developed a novel selection method to isolate isogenic T. vaginalis para-
sites that differ in their ability to bind host cells. This method takes advantage of
reported observations that T. vaginalis in vitro adherence to culture tubes is correlated
with its ability to bind host cells, both in vitro and in vivo (30, 31). We report the identi-
fication of the surface-expressed TVAG_157210 (TvAD1) protein and characterize its
role in T. vaginalis adherence to the host. TvAD1 is a parasite surface-expressed protein
predicted to interact with the host surface via binding of N-acetylglucosamine—a com-
ponent of the host glycosaminoglycan heparan sulfate (HS). We subsequently demon-
strated the role of host cell HS in parasite adherence. To our knowledge, this is the first
report of a T. vaginalis surface protein interacting with host glycosaminoglycans to ini-
tiate parasite adherence to the host.
RESULTS
Enrichment of T. vaginalis surface proteins. Previous analyses of the surface pro-
teomes of 3 highly adherent and 3 lowly adherent T. vaginalis clinical isolates deter-
mined that surface proteins are differentially expressed on strains, conferring varying
adherence to the host as a result. However, the highly variable expression of predicted
surface proteins (26) by different T. vaginalis strains limited these analyses. To eliminate
this issue, we developed a method that would allow us to study increased parasite ad-
herence to host cells using an isogenic, clonal strain of T. vaginalis. Taking advantage
of the observation that the parasite’s in vitro adherence to culture tubes is correlated
with its ability to bind host cells, both in vitro and in vivo (30, 31), we selected parasites
from the isogenic culture by passaging only parasites bound to the tubes (Fig. 1A).
After 8weeks of daily passaging of only culture tube-adherent parasites, we obtained
an isogenic strain, called more adherent (MA). The original parental (P) strain was also
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passaged daily for 8weeks without selection. Adherence assays were then done to
quantify and compare the adherence of MA (see Fig. S1A in the supplemental material)
and P (Fig. S1B) strains to benign prostate hyperplasia 1 (BPH-1) cells. We found that
our selection approach significantly increased adherence of MA to host cells by
approximately 6-fold compared with that of P (Fig. 1B). These isogenic parasite popula-
tions that differ in their adherence to host cells set the stage for identifying membrane
proteins that are more abundant in MA parasites and hence possibly involved in para-
site adherence to the host.
TMT multiplex proteomic analysis identified differences in the abundance of
proteins between MA and P parasites. Our laboratory and others have successfully
used biotinylation of surface proteins to obtain enriched surface protein fractions for
use in proteomic studies (26, 32, 33). Using membrane-impermeable sulfo-NHS-SS-bio-
tin (sulfosuccinimidyl-2-[biotinamido]ethyl-1,3-dithiopropionate), the surface mem-
brane proteins of both MA and P populations were labeled. Protein labeling was con-
firmed by indirect immunofluorescence assay (IFA) using 488-conjugated streptavidin.
Staining was confined to the surface and shows minimal cytosolic staining (see Fig. S2A
in the supplemental material), demonstrating that the surface proteins were selectively
FIG 1 Enrichment of parasites with increased adherence to host cells. (A) Schematic for selective
enrichment of T. vaginalis. Clonal population was used to generate two isogenic populations, namely,
more adherent (MA) and parental (P). The MA population resulted from passaging culture tube-
bound parasites daily. The P population was passaged without selection of tube-bound parasites.
Changes in adherence to BPH-1 cells was measured using our standard adherence assay (18). (B)
Adherence to BPH-1 cell monolayers by MA and P parasites passaged for 8 weeks. The mean of three
experiments each done in triplicate is shown 6 SEM. Statistical significance was determined using
Student’s t test.
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biotinylated. In addition, the membrane-enriched fractions from biotinylated and control
nonbiotinylated samples were compared by SDS-PAGE and streptavidin-horseradish per-
oxidase (HRP) Western blot. Similar protein profiles were seen between the samples fol-
lowing SDS-PAGE separation (Fig. S2B, left panel) confirming equivalent extraction
between samples. As expected, only the biotinylated sample showed signal on the strepta-
vidin-HRP Western blot (Fig. S2B, right panel), confirming that surface proteins were biotin-
ylated and that the likelihood of proteins in the control samples binding streptavidin-con-
jugated proteins is quite low.
The parasite membrane and the subsequent biotinylated proteins were then frac-
tionated via centrifugation using freeze-thaw cell lysis followed by sonication. This
membrane-enriched fraction was detergent-solubilized to release the proteins and was
passed through a streptavidin affinity column to enrich for biotinylated proteins. To
identify surface proteins and their relative abundance levels on MA and P, three biolog-
ically independent surface-enriched samples from each were labeled with tandem
mass tag (TMT) isobaric labels for downstream quantitative analysis using liquid chro-
matography-tandem mass spectrometry (LC-MS/MS) (34, 35). Analysis of protein identi-
fications obtained from the MA and P samples identified 365 total T. vaginalis proteins
(see Table S1 in the supplemental material). Of these proteins, 22% were predicted to
be membrane proteins based on the previously published surface membrane pro-
teome and analysis of the T. vaginalis genome (19, 26). To graphically represent the
quantitative data, a volcano plot of 2log10(P value) versus log2(fold change: MA/P) was
constructed (Fig. 2). Data points to the right of the right-most non-axial vertical line,
colored red, denote proteins which exhibited fold changes of MA/P greater than 2.
After excluding contaminating proteins which include abundant hydrogenosomal and
ribosomal proteins that are common contaminants of subcellular fractions and have
been found to contaminate all subcellular fractions of T. vaginalis that we have sub-
jected to proteomic analyses (26, 29, 36), 28 proteins identified by this multiplexed pro-
teomics approach were predicted to be membrane or membrane-associated proteins
with a 2-fold or greater abundance in MA than in P (Table 1). Several proteins were
found to be less abundant in MA than in P by 2-fold or more; the gene number and
description of these proteins are listed in Table S2 in the supplemental material.
The predicted functions and gene copy number of the proteins found to have the
highest increase in abundance in MA relative to P were examined. Similar multicopy
genes that give rise to proteins that cannot be differentiated by the proteomic data
are referred to as protein groups. The 2 top-ranked protein groups, TVAG_293660 and
TVAG_335250/TVAG_477640, belong to large protein families (https://trichdb.org/
trichdb/) which would complicate functional analyses. The next most abundant protein
group (TVAG_ 228160, TVAG_150940, and TVAG_539120) is predicted to include
FIG 2 Multiplex proteomics illustrate differentially abundant proteins in MA compared with those in
P. A total of 365 proteins were identified by proteomics analyses of MA and P, in triplicate (see Table
S1). Volcano plot of 2log10(adjusted P value) is plotted against log2(fold change: MA/P) as measured
by TMT multiplexing and LC-MS/MS. The non-axial vertical line denotes$2-fold change protein
abundance of MA versus P. Red points correspond to proteins 2-fold or higher in abundance MA/P.
The single green point corresponds to TvAD1 (TVAG_157210). Statistical analysis was performed for
triplicate samples by two-sided t test.
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cytoskeletal-associated proteins that may be in close contact with the plasma mem-
brane. As manipulation of cytoskeletal proteins is likely to result in complex pheno-
types, which may indirectly affect parasite binding, we chose not to pursue these
proteins.
A hypothetical protein, without similarity to other known proteins, TVAG_157210,
was the 5th most abundant protein/protein group identified, with ;4-fold higher
abundance on MA parasites. BLAST analyses (https://blast.ncbi.nlm.nih.gov/Blast.cgi) of
TrichDB failed to find homologues, demonstrating that TVAG_157210 is a single-copy
gene in the T. vaginalis genome. As a first step toward characterizing this protein, topo-
logical analysis using the TOPCONS consensus prediction of membrane protein topol-
ogy program was used (37). These analyses indicate that TVAG_157210 contains a sin-
gle transmembrane domain at the C terminus at positions 275 to 295, predicting that
the bulk of the protein is exposed on the outer surface of the parasite. We then used
InterPro (38) and Pfam (39) analyses which failed to detect any functional domains.
Protein structure prediction software predicts TVAG_157210 to be involved in cell ad-
hesion and/or protein binding, albeit with a low confidence interval due to the lack of
suitable protein structure templates for modeling (40, 41). However, de novo modeling
by the i-TASSER program in conjunction with the 3DLigandSite program suggested
that TVAG_157210 binds N-acetylglucosamine (GlcNAc) (42, 43). Given that proteogly-
cans, of which some contain high levels of GlcNAc, are known to be displayed on the
epithelial cells T. vaginalis binds to in the urogenital tract (44–46) and other pathogens
are known to utilize proteoglycans for host cell attachment (47–50), we decided to vali-
date and further investigate this protein, which we renamed Tv adherence protein 1
(TvAD1).
TABLE 1 Differentially expressed predicted membrane or membrane-associated proteinsa
Protein
features
Locus Description Fold change TMDb MAPc Reference
TVAG_293660 Conserved hypothetical protein 14.47 26
TVAG_477640; TVAG_335250 Conserved hypothetical protein 10.63 Yes 26, 29
TVAG_228160; TVAG_150940; TVAG_203740 Coactosin 4.62 Yes
TVAG_539120 Conserved hypothetical protein 4.30 26
TVAG_157210 Conserved hypothetical protein 4.09 Yes 26
TVAG_226630 Conserved hypothetical protein 3.93
TVAG_464410 AMP dependent ligase/synthetase 3.86
TVAG_222040 4-a-Glucanotransferase 3.45 26
TVAG_407150; TVAG_419690 arp2/3 Complex 16-kD subunit 3.20 Yes
TVAG_270790 N-Acylglucosamine-2-epimerase 2.87
TVAG_369030 Clathrin heavy chain 2.86 Yes
TVAG_270770 Conserved hypothetical protein 2.81
TVAG_283380 FMR1-interacting protein 2.69
TVAG_321740 Conserved hypothetical protein 2.67 Yes 26
TVAG_369020; TVAG_558650; TVAG_516070; TVAG_502180 Clathrin heavy chain 2.54 Yes 26
TVAG_348080 Calcium-transporting ATPase 2.50 Yes
TVAG_180570 FERM domain protein 2.49 Yes
TVAG_151920; TVAG_429360; TVAG_145570 WD repeat domain protein 2.37
TVAG_376130 Gelosin 2.32 Yes
TVAG_028160 Cation-transporting ATPase 2.31 Yes 26
TVAG_000810 Conserved hypothetical protein 2.30
TVAG_147050 Conserved hypothetical protein 2.25 Yes 26
TVAG_258230 Conserved hypothetical protein 2.19 Yes 26
TVAG_013580 Hypothetical protein 2.16
TVAG_059980 Conserved hypothetical protein 2.15 Yes 26
TVAG_000880 GP63-like 2.14 Yes 19, 26
TVAG_038850 Conserved hypothetical protein 2.13 Yes 26
TVAG_185680 Conserved hypothetical protein 2.00 Yes 26
aWith a 2-fold or higher abundance in membrane-enriched fractions of MA parasites than that of P parasites.
bTMD, transmembrane domain.
cMAP, membrane-associated protein.
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As a first step to validate the increased abundance of TvAD1 on MA parasites, we
compared TvAD1 mRNA levels between MA and P parasites, using real-time quantita-
tive reverse transcription-PCR (qRT-PCR). TvAD1 mRNA levels were found to be 1.82-
fold (P=0.0005) greater in MA than in P, consistent with increased protein levels in the
MA versus P surface proteome (see Fig. S3 in the supplemental material). Furthermore,
to confirm that TvAD1 alone was capable of conferring an increased adherence pheno-
type, TvAD1 was exogenously expressed in the poorly adherent G3 strain by nucleo-
fecting the parasites with our standard T. vaginalis expression vector where expression
of the TvAD1 gene was driven by the alpha succinyl-CoA-synthetase (aSCS) promoter
(26, 51, 52). Expression of the C-terminal tagged TvAD1 protein was confirmed by anti-
hemagglutinin (HA) Western blot (see Fig. S4A in the supplemental material). The ad-
herence of parasites overexpressing TvAD1 and G3 parasites containing an empty vec-
tor (EV) were then compared. Increased expression of TvAD1 in the poorly adherent
parasites significantly increased attachment to BPH-1 cells ;2.6-fold compared with
parasites nucleofected with EV (P=0.007) (Fig. S4B). These data directly demonstrate
that TvAD1 plays a role in T. vaginalis adherence to the host.
Mammalian glycosaminoglycans play a role in MA parasite adherence to
epithelial cells. GlcNAc belongs to a large class of amino sugars that comprise the gly-
cosaminoglycan (GAG) heparan sulfate (HS) (51) found on epithelial cells and in the
extracellular matrix (52). To determine if GAGs play a role in T. vaginalis adherence, we
used Chinese hamster ovary (CHO) cell lines generated by Jeffrey Esko and colleagues
that lack surface HS (DHS), a component of GAGs, or all GAGs (DGAG) (53, 54).
Compared with the wild-type CHO cell line (WT), a reduction in adherence of MA para-
sites of 36% (P = 0.013) and 57% (P = 0.001) was observed using DHS cells and DGAG
cells, respectively (Fig. 3A). In contrast, adherence of the isogenic P parasites was not
significantly reduced on DHS or DGAG cells, showing a 21% (P = 0.785) and 15%
(P = 0.878) reduction in adherence, respectively, compared with that of WT (Fig. 3B).
These observations indicate that host glycosaminoglycans mediate adherence of MA
to host cells.
FIG 3 Increased adherence of MA strain mediated by host cell proteoglycans. Ability of MA (A) and P
(B) parasites to adhere to wild-type (WT), heparan sulfate-deficient (DHS), and GAG-deficient (DGAG) CHO
cell monolayers was quantified following a 30-min incubation. Data shown are the means 6 SEM from
independent experiments, with each performed in triplicate. Statistical significance was determined using
a one-way analysis of variance (ANOVA) with Tukey’s multiple-comparison test.
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CRISPR-Cas9 gene knockout of TvAD1 significantly reduced MA parasite
adherence to host cells. To further elucidate the role of TvAD1 in host cell adherence,
CRISPR-Cas9 gene editing, which we recently established in T. vaginalis (55), was employed
to knock out the gene. Using homology-directed repair, the TvAD1 gene in MA parasites
was replaced with the neomycin resistance gene flanked by arms homologous to the 59
and 39 untranslated regions (UTRs) of TvAD1 to allow selection of TvAD1 gene knockout
parasites. Confirmation of the loss of TvAD1 from the genome was done using three differ-
ent PCRs (Fig. 4A). Integration of the knockout cassette in the correct locus was confirmed
by PCRs amplifying from the 59 UTR or 39 UTR of the gene into the newly integrated neo-
mycin gene. As expected, the TvAD1 knockout (TvAD1-KO) parasites present an amplicon
of expected size in both the 59 UTR 1 neo (top panel) and 39 UTR 1 neo (middle panel)
exhibiting the predicted sizes of 1,469bp and 1,419bp, respectively. The third PCR con-
firmed the absence of the TvAD1 in the genome, compared with WT MA parasites (bottom
panel). These data confirm that we successfully knocked out TvAD1 in MA parasites.
Having knocked out TvAD1 from MA parasites, the TvAD1-KO parasites were then
assayed for their ability to adhere to host cells. TvAD1-KO parasites exhibited a 49%
reduction in adherence to BPH-1 cells compared with the MA wild-type parasites
(P=0.0005) (Fig. 4C). To ensure that the loss in adherence observed in TvAD1-KO was
specific to the absence of TvAD1, TvAD1 levels were partially restored by exogenously
expressing TvAD1 with 2 HA at the C terminus and assayed to determine if the KO
phenotype was rescued. Western blot analysis using an anti-HA antibody confirmed
that the TvAD1 protein was being expressed in the TvAD1-add back strain (Fig. 4B).
When assayed for changes in adherence, we found that TvAD1-add back parasites
exhibited a partial KO rescue at 84% adherence to BPH-1 cells compared with that of
MA (P = 0.0005) (Fig. 4C). In addition, TvAD1-add back adherence was significantly res-
cued compared with that of TvAD1-KO (P=0.0148). Together, these results provide de-
finitive evidence that TvAD1 plays a role in adherence of T. vaginalis to host cells.
TvAD1 is necessary for heparan sulfate-mediated adherence of MA parasites to
host cells. With functional analyses having confirmed TvAD1 plays a role in parasite
adherence to host cells and bioinformatic analyses suggesting an interaction between
TvAD1 and GlcNAc, we asked whether the presence or absence of TvAD1 affects MA
parasite binding to DHS and DGAG CHO cell lines by comparing binding of the TvAD1-
KO and TvAD1-add back parasites. Unlike the significant decrease in adherence of MA
to DHS cells shown in Fig. 3, we observed that adherence of TvAD1-KO parasites to
DHS cells is not significantly decreased (P=0.52) compared with WT (Fig. 5A).
Adherence of TvAD1-KO to DGAG was significantly decreased by 48% (P=0.003), con-
sistent with data demonstrating that T. vaginalis adherence to host cells is multifacto-
rial (21). In contrast, adding back TvAD1 to KO parasites resulted in a significant
decrease in adherence of 34% (P=0.02) (Fig. 5B), similar to the adherence observed for
WT MA to DHS cells (Fig. 3A). Likewise, adherence of TvAD1-add back parasites to
DGAG cells was significantly decreased by 51% (P=0.0006) relative to adherence to
WT CHO cells. Analysis of TvAD1-KO and TvAD1-add back parasite adherence to WT
CHO cells revealed that adherence was significantly reduced by ;30% (P=0.01) in the
absence of TvAD1 (Fig. 5C), which is similar to what was observed for these strains on
BPH-1 cells (Fig. 4C). Conversely, TvAD1-KO parasites exhibited ;7% reduction in ad-
herence to DHS cells compared with TvAD1-add back (P=0.62), demonstrating that
episomal expression of TvAD1 conferred the increased adherence seen in the TvAD1-
add back parasites and that it was mediated through an interaction with HS on the
host surface. Adherence to DGAG by TvAD1-KO parasites exhibited;23% lower adher-
ence than that of TvAD1-add back parasites (P=0.008), suggesting that TvAD1 may
also be interacting with other proteins on the host cell surface to mediate adherence
even in the absence of all GAG molecules. These data further confirmed a role for host
GAG molecules in T. vaginalis adherence to the host and strongly indicated that
TvAD1-mediated adherence requires the presence of host cell heparan sulfate.
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Thermodynamic analysis determined an interaction between TvAD1 and heparan
sulfate. To measure whether TvAD1 interacts with HS, we employed an isothermal ti-
tration calorimeter (ITC) to measure the thermodynamics that would be associated
with this interaction. Recombinant TvAD1 protein (rTvAD1), lacking its short,
FIG 4 CRISPR-Cas9 knockout of TvAD1 significantly reduces adherence of MA parasites to BPH-1 cell monolayers. (A)
PCR analysis of the TvAD1 knockout (TvAD1-KO) and wild-type (WT) parasites for the presence of the neo gene in the
TvAD1 locus. PCRs using primers to amplify the 59 UTR integration site (5UTR_For 1 Neo_Rev) yielded the expected
1,469-bp product (top panel), while primers used to amplify the 39 UTR integration (Neo_For1 3UTR_Rev) yielded the
expected 1,419-bp product (middle panel), showing that the neomycin gene is present in the TvAD1 locus. The intact
TvAD1 locus product of 2,084 bp detected in WT parasites using primers located upstream of the 59 integration site
and within the TvAD1 gene (5UTR_For1 157internal_Rev (bottom panel) is absent in TvAD1-KO parasites. (B) Episomal
expression of a C-terminal 2 HA-tagged TvAD1 protein in the KO background (TvAD1-add back) was confirmed by
anti-HA immunoblot analyses and compared with parasites transfected with empty vector (EV). Hsp-70 was used as a
loading control. Expected sizes for Hsp-70 and TvAD1-add back are ;70kDa and ;37kDa, respectively. The black line
between TvAD1-add back and EV indicates the blot was spliced to remove a lane between the samples. (C) Attachment
of TvAD1-KO and TvAD1-add back to BPH-1 cell monolayers was quantified and compared with the attachment of MA
parasites. Data shown are means of triplicate biological replicates, which were performed in triplicate 6 SEM. Statistical
significance was determined using a one-way ANOVA with Tukey’s multiple-comparison test.
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hydrophobic C-terminal transmembrane domain to increase solubility and protein
refolding, was generated and isolated using 8 M urea under denaturing conditions.
Protein purification was confirmed by SDS-PAGE and Coomassie staining (see Fig. S5 in
the supplemental material). The protein was then refolded by stepwise dialysis to
remove urea, and refolding was confirmed using intrinsic tryptophan fluorescence
measurements. Folded rTvAD1 exhibited a peak emission wavelength (lmax) of 337 nm,
which is well within the expected 330 -to 345-nm range for folded proteins (see Fig. S6
in the supplemental material). We tested the TvAD1-HS interaction by titrating HS onto
rTvAD1 and measuring the heat change associated with this interaction. The resulting
heat changes were integrated and fitted to obtain thermodynamic parameters of bind-
ing. With progressive HS injections, the thermogram, displayed by clear and distinct
peaks, decreased as more TvAD1 bound HS but failed to reach saturation (Fig. 6). The
heat changes were fitted accordingly to the predicted number of GlcNAc binding sites
FIG 5 The loss of heparan sulfate on CHO cells significantly decreases adherence of TvAD1-add back
parasite but not TvAD1-KO adherence. TvAD1-KO (A) and TvAD1-add back parasites exogenously
expressing TvAD1 in the knockout background (B) were measured for their adherence to wild-type
(WT), heparan sulfate-deficient (DHS), and GAG-deficient (DGAG) CHO cell monolayers. (C) Comparison of
TvAD1-KO and TvAD1-add back parasite adherence to CHO cell monolayers. Data shown are means of
independent experiments done in triplicate 6 SEM. Statistical significance for A and B was determined
using a one-way ANOVA with Tukey’s multiple-comparison test and unpaired t test for C.
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present on the protein. A two-sequential binding site model for TvAD1 was the best fit
with dissociation constants (Kd) of 10.57mM and 9.62mM, respectively. These analyses
demonstrate that TvAD1 binds HS.
DISCUSSION
Using a novel selection method to create isogenic parasites that differ in their abil-
ity to adhere to host cells, followed by proteomic and bioinformatic analyses, we have
identified and characterized a T. vaginalis surface protein, TvAD1 (TVAG_157210). We
have shown that TvAD1 binds host cell glycosaminoglycans (GAGs) increasing parasite
adherence to host cells. Quantitative analyses of the cell surface proteomes of more
adherent (MA) and parent (P) isogenic parasites identified 29 surface proteins that
are .2-fold more abundant in MA than in P parasites. Subsequent knockout of TvAD1
from MA parasites, which was found to be 4.13-fold more abundant than in P parasites,
using CRISPR-Cas9, showed that the loss of TvAD1 significantly reduced the parasite’s
enhanced adherence capacity. Further investigation by assaying adherence to GAG-de-
ficient cell lines and ITC analysis identified host HS as necessary for parasite adherence
by TvAD1. Previous studies using pathogenic bacteria and viruses that bind to and
modify HS have established a role for GAG molecules in host colonization (47–50).
However, to our knowledge, this is the first report of a T. vaginalis surface protein inter-
acting with host cell GAG molecules and thereby enhancing parasite adherence to the
host.
T. vaginalis adherence to the host epithelium is a multifaceted process in which a
number of parasite factors have been shown to play a role (19, 24–29, 36, 56–58).
FIG 6 Measuring interaction between TvAD1 and heparan sulfate by ITC. Binding interaction between
TvAD1 protein (146.2mM) and heparan sulfate (HS) (1mg/ml) was measured using ITC at 25°C. Initial
injection was 0.2ml of HS followed by 19 injections of 2ml each applied with an interval of 3min.
The binding isotherm profile was obtained excluding the initial data point. The top panel depicts
the calorimetric output during the injection of HS into the rTvAD1 solution. The bottom panel
depicts the binding isotherm.
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Unlike previous proteomic analyses exploited to identify these factors, our use of iso-
genic strains for proteomic analysis and comparison not only allows for the identifica-
tion of membrane proteins involved in adherence but also safeguards against detection
of proteins that are not involved in parasite adherence but simply differ in abundance
between strains.
Of the 29 membrane or membrane-associated proteins found to be .2-fold more
abundant in MA parasites, 14 were identified in the previous proteome analyses as
more abundant in 3 highly adherent versus 3 poorly adherent T. vaginalis strains (26),
of which 2 were further characterized in additional studies (29, 59). The presence of ad-
herence proteins, such as cadherin-like protein (26, 27) and BspA-like proteins (19, 60,
61) in our data set, further validates our approach.
A 4-a-glucanotransferase (TVAG_222040) was also found to be .3-fold more abun-
dant in MA parasites (Table 1). This finding is notable as we recently showed that a
member of this protein family found on the surface of T. vaginalis extracellular vesicles
that is 88% identical to TVAG_222040 binds to HS, as well as to GAGs on the surface of
host cells (59). The observation that two unrelated proteins, which bind HS and host
cell GAGs, are increased in abundance of MA parasites underscores the likely impor-
tance of the interaction of T. vaginalis surface proteins and host cell proteoglycans in
parasite adherence, a necessary step in colonization of the host urogenital tract.
In humans, the amino sugar N-acetylglucosamine (GlcNAc) is most commonly
found comprising GAGs—large polysaccharides present on the proteoglycans of epi-
thelial cells and extracellular matrix (52). Belonging to a large class of amino sugars,
which serve a number of functions throughout the human body, GlcNAc is well known
for its role in comprising the GAG heparan sulfate (HS) (51). We demonstrated that
TvAD1 specifically binds HS and that mammalian cells lacking HS are deficient in bind-
ing MA parasites. Unlike MA, the adherence of P parasites was not significantly
changed in the absence of any GAG molecule on the mammalian cell, suggesting that
our novel adherence selection method selected for carbohydrate-binding factors. As
the culture tubes lack a bioavailability of cellular factors, it is possible that the horse se-
rum in our culture media provided complexes of proteins, lipids, and carbohydrates
coating the culture tube to which the parasite surface molecules bind.
Analysis of the function of TvAD1 led us to employ CRISPR-Cas9 (55) to knock out
the protein to directly ascertain whether it plays a role in adherence, more specifically
HS-mediated adherence. Knock out of TvAD1 significantly reduced MA adherence to
host cells and exogenously expressed TvAD1-add back partially restored the lost ad-
herence phenotype. The lack of a full restoration of the adherence phenotype in the
KO add back parasites is likely due to reduced levels of TvAD1 in the parasite mem-
brane, relative to MA parasites. Notably, KO parasites showed no significant difference
in adherence to HS-deficient host cells compared with the wild type. Moreover, when
TvAD1 is added back to the KO parasites, a significant difference in binding to wild-
type and the HS-deficient host cells reappears, thus signifying a necessary role for
TvAD1 in HS-mediated adherence of MA parasites to host cells.
A direct interaction between TvAD1 and HS was shown using ITC analyses. While a
two-sequential binding site model for TvAD1 is predicted as the best fit, ITC results
were unable to show an affinity interaction between the two molecules, signifying that
the interaction between HS and TvAD1 is not strong and may be one of avidity rather
than affinity. The TvAD1 and HS interaction data suggest that TvAD1 requires the pres-
ence of additional T. vaginalis surface proteins to either initiate or stabilize adherence
to host cells. Nevertheless, together, these findings provide definitive evidence that T.
vaginalis binds GAG molecules for adherence to host cells and that TvAD1 plays a role
in this interaction via interaction with host HS molecules.
Whether other proteins or protein families involved in parasite adherence interact
with host GAG molecules has yet to be determined. With the goal of possibly design-
ing therapeutic targets to inhibit the establishment of infection, a better understand-
ing of the types and importance of T. vaginalis adherence factors will be necessary.
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Parasites, cell culture, and media. T. vaginalis strains LSU 160 and G3 (ATCC PRA-98; Kent, UK) were
cultured in Diamond’s modified Trypticase-yeast extract-maltose (TYM) medium supplemented with
10% horse serum (Sigma-Aldrich), 10 U/ml penicillin and 10mg/ml streptomycin (Gibco), 180mM ferrous
ammonium sulfate, and 28mM sulfosalicylic acid (62, 63). Parasites were grown at 37°C and passaged
daily. Human benign prostate hyperplasia 1 (BPH-1) epithelial cells were cultured in RPMI 1640, L-gluta-
mine, and HEPES media (Gibco) supplemented with 10 U/ml penicillin, 10mg/ml streptomycin, and 10%
fetal bovine serum (FBS; Gibco) as previously described (64). K1 wild-type Chinese hamster ovary (CHO)
cell line was obtained from ATCC (CCL-61). CHO proteoglycan mutant D677 (heparan sulfate defective,
DHS) and A745-23A1 (GAG deficient, DGAG) cells (53, 54) were a gift from Jeffrey D. Esko, University of
California San Diego, La Jolla, CA. CHO cell lines were cultured in F12 medium (Gibco) supplemented
with 10% FBS and 10 U/ml penicillin and 10mg/ml streptomycin. BPH-1 and CHO lines were grown at
37°C with 5% CO2.
Parasite selection for increased adherence. A clonal population of T. vaginalis strain LSU 160 was
derived using limiting dilution cloning. To select for the more adherent (MA) parasite, this clonal popula-
tion of parental (P) parasites was cultured for ;24 hours, after which all free-floating, unbound parasites
were discarded. The culture tube was then filled with fresh completed Diamond’s media, incubated on
ice for 10min, and vortexed for 30 sec to release bound parasites. These parasites were counted by
hemocytometer and passaged at a dilution of 5 104 cells/ml into 50ml fresh Diamond’s media. This
selection process was carried out daily for 8weeks. P parasites were passaged daily as previously
described (18). Briefly, overnight cultures of P parasites were placed on ice for 10min and then vortexed
for 30 sec before being passaged at a dilution of 5 104 cells/ml into 50ml fresh Diamond’s media.
Attachment assay. Attachment of T. vaginalis parasites to BPH-1 was performed as previously
described (18). Briefly, epithelial cells were seeded on 12-mm coverslips in 24-well plates at 1.75 105
cells/well in culture medium and grown to confluence at 37°C with 5% CO2 for 2 days. Coverslips were
washed with fresh complete RPMI medium prior to the addition of parasites. T. vaginalis was labeled
with 10mM CellTracker red CMTPX dye (Invitrogen), and 105 labeled parasites were added to the mono-
layers in triplicate. Plates were incubated at 37°C in 5% CO2 for 30min. The coverslips were washed in
phosphate-buffered saline (PBS) to remove unbound parasites, fixed in 4% formaldehyde in PBS, and
mounted on slides using Mowiol (Calbiochem). Fifteen images were taken per coverslip with three cov-
erslips per condition using an Axioskop 2 epifluorescence microscope (Zeiss). Cell counts were quanti-
fied using Zen (Zeiss) and ImageJ (65) software. The scoring and counting of all images were performed
in a blind fashion. Attachment of T. vaginalis parasites to CHO cells was performed as previously
described with one modification—complete F12 medium was used as the culture medium. All attach-
ment assay data are normalized and shown as fold change in adherence 6 SEM. All non-normalized
data are provided in Fig. S7 in the supplemental material and are shown as the average number of para-
sites per coverslip 6 SEM from triplicate experiments.
Biotinylation of surface membrane proteins and purification from membrane fractions.
Biotinylation of T. vaginalis cell surface proteins was performed as described previously (26) with modifi-
cations. Briefly, 2 108 parasites were collected and washed twice with prechilled PBS-sucrose (PBS-S;
5% sucrose) and then incubated with 0.5mg/ml EZ-Link sulfo-NHS-SS-biotin (Thermo Scientific) in PBS-S
on ice for 45min. The reaction was quenched by adding 50mM Tris-HCl (pH 7.4) and incubating on ice
for 15min. Biotinylation of the parasite membrane was confirmed by immunofluorescence assay using a
streptavidin-488-conjugated antibody as previously described (26) and streptavidin-HRP Western blot.
Biotinylated parasites were then washed three times with prechilled PBS-S and subjected to freeze-thaw-
ing. Clarification of the homogenate by centrifugation (14,000 rpm for 30min at 4°C) was carried out to
reduce cytosolic background. The membrane-enriched pellet was solubilized in 0.5ml of lysis buffer
(50mM Tris-HCl [pH 8], 5mM EDTA, 150mM NaCl, 0.1% deoxycholate, 1% dodecylmaltoside, and HALT
protease inhibitor), subjected to 3 sonication cycles (5-sec sonication, 30-sec recovery on ice), and incu-
bated at 4°C for 16 to 18 h on a rotating mixer to solubilize the protein out of the membrane fraction.
Streptavidin Sepharose high-performance slurry (150ml/mg total proteins; GE Healthcare Life Sciences)
was equilibrated by five washes in lysis buffer, and binding of biotinylated proteins was allowed to pro-
ceed overnight on a rotating mixer at 4°C. The resin was washed once with each of the following sterile
buffers using 7 bead volume: A (6 M urea, 1% dodecylmaltoside, 1% deoxycholate, 150mM NaCl, and
100mM Tris-HCl [pH 8]), B (6 M urea, 0.1% dodecylmaltoside, 0.1% deoxycholate, 500mM NaCl, 100mM
Tris-HCl [pH 8], 3.7% EtOH, and 3.7% isopropanol), and C (6 M urea and 100mM Tris-HCl [pH 8]). After
the final wash, the resin was resuspended in 50mM tris(2-carboxyethyl)phosphine hydrochloride (TCEP)
in 100mM Tris-HCl (pH 8) and incubated at room temperature for 1 h on a rotating mixer in the dark to
cleave off the biotin from the protein sample. Capture of biotinylated proteins was checked by SDS-
PAGE and Western blot analysis using streptavidin-HRP (Thermo Scientific). Protein samples were snap-
frozen and lyophilized.
Proteolytic digestion and TMT 10plex labeling. Lyophilized protein samples were proteolytically
digested in solution as previously described with modifications (35, 66). Protein samples were resus-
pended in 8 M urea in 100mM Tris-HCl (pH 8.5) and reduced with 500mM TCEP for 20min. Reduced cys-
teines were subsequently alkylated with 500mM iodoacetamide for 15min at room temperature (RT) in
the dark. A total of 0.1mg/ml Lys-C endopeptidase (Fujifilm Wako Chemicals, USA) was then added and
the samples incubated at RT in the dark for 4 h to initiate proteolysis. The samples were then diluted
using 100mM Tris-HCl (pH 8.5) to a final concentration of 2 M urea and adjusted to 1mM CaCl2. To gen-
erate peptides, 0.56mg/ml mass spectrometry-grade trypsin (Promega WI) was added, and the samples
were then incubated at RT in the dark for 16 to 18 h. Protein digestion was quenched by the addition of
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formic acid to a final concentration of 5% and lyophilized. Lyophilized protein samples were resus-
pended in 100mM triethylammonium bicarbonate (TEAB) to eliminate the presence of primary amines
and then labeled with TMT 10-plex labeling, according to the manufacturer’s protocol (Thermo
Scientific). The pooled samples were desalted by high-performance liquid chromatography (HPLC) using
an Optimize Technologies C8 microtrap cartridge. The desalted samples were lyophilized and then resus-
pended in 0.2% formic acid, which made them ready for LC-MS/MS analysis.
Mass spectrometry analysis. Desalted peptides were analyzed using a 26-cm analytical HPLC col-
umn (75-mm inner diameter) packed in-house with ReproSil-Pur C18AQ 1.9-mm resin (120-Å pore size;
Maisch, Ammerbuch, Germany). After being loaded, the peptides were separated with a 120-min gradi-
ent at a flow rate of 200 nl/min at 50°C (column heater) using the following gradient: 2% to 6% solvent
B (7.5min), 6% to 25% B (82.5min), 25% to 40% B (30min), 40% to 100% B (1min), and 100% B (9min),
where solvent A was 97.8% H2O, 2% acetonitrile (ACN), and 0.2% formic acid and solvent B was 19.8%
H2O, 80% ACN, and 0.2% formic acid. The Orbitrap Fusion instrument (Thermo Scientific) was operated
in data-dependent acquisition mode with SPS-MS3 to automatically switch between an MS1 scan (m/
z= 400 to 1,500) in the Orbitrap (120,000 resolution), an MS2 scan using collision-induced dissociation
(CID) fragmentation and detection in the ion trap (with turbo scan rate), and an SPS-MS3 scan using
higher-energy C-trap dissociation (HCD) fragmentation (65 normalized collision energy [NCE] on the top
10 most intense MS2 ions) and detection in the Orbitrap (60,000 resolution). The automatic gain control
(AGC) targets of the MS1, MS2, and MS3 scans were 4E5, 1E4, and 1E5, respectively. Monoisotopic pre-
cursor selection was enabled, as well as charge state filtering (only charge states 2 to 7, ignoring unde-
termined charge states), minimum intensity threshold of 5,000, and dynamic exclusion of 60 seconds.
Thermo raw files were searched using MaxQuant (v. 1.5.5.1) (67, 68). Spectra were searched against
UniProt T. vaginalis sequences (50,190 entries) and a contaminant database, including proteins like tryp-
sin and human keratins (246 entries). A decoy database of reversed sequences was also included to esti-
mate the false discovery rate. Trypsin was the specified digestion enzyme, and up to two missed clea-
vages were allowed. Methionine oxidation and protein N-terminal acetylation were specified as variable
modifications. Carbamidomethylation of cysteine and TMT10plex modification of peptide N terminus
and lysine were specified as fixed modifications. Precursor mass tolerance was 4.5 ppm after mass recali-
bration, MS2 ion mass tolerance was 0.5 Da, and MS3 ion mass tolerance was 0.003Da. Score thresholds
were set to achieve a 1% false discovery rate at the protein, peptide, and peptide-spectrum match levels.
Calculation of iBAQ values was enabled. Proteins were further analyzed using limma (69), where a mod-
erated t test was performed between protein abundances in different sample types. P values were
adjusted using the Benjamini and Hochberg method.
Bioinformatic analyses. Topology of the TVAG_157210 protein was determined using TOPCONS
(37). To predict TVAG_157210 function, we used Phyre2 (40), I-TASSER (42), 3DLigandSite (43), InterPro
(38), Pfam (39), and PredictProtein (41) programs to analyze protein sequences and generate a protein
structure de novo. The gene and protein sequences of TVAG_157210 were also analyzed via NCBI BLAST
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) to compare them against all sequences published on TrichDB
(https://trichdb.org/trichdb/) as well as other organisms to search for homologues.
Real-time quantitative reverse transcription-PCR. A total of 2 107 LSU160 MA and P parasites
were resuspended in TRIzol to collect RNA using the Direct-zol RNA MiniPrep Plus kit (Zymo Research)
following the manufacturer’s protocol. Total RNA was treated with TURBO DNA-free amplification grade
DNase I (Invitrogen) and reverse transcribed using SuperScript III reverse transcriptase and oligo(dT) pri-
mers (Invitrogen). Real-time PCRs were performed using Platinum SYBR green qPCR SuperMix-UDG fol-
lowing the manufacturer’s protocol (Invitrogen). T. vaginalis b-tubulin was used as the housekeeping
gene control. The primers for b-tubulin were Tub-For (59-GGCTCGTAACACATCCTACTTC-39) and Tub-Rev
(59-CTGTTGTGTTGCCGATGAATG-39). The primers for TvAD1 were TvAD1_qPCR-For (59-TGTTGGTGGCC
TTCCAGTTTG-39) and TvAD1_qPCR-Rev (59-TCTGAGCAGCAGCACTTCTTG-39). Primer specificity was
checked using NCBI Primer-BLAST which indicated the primer pairs unique to the T. vaginalis sequences
(70).
CRISPR-Cas9-mediated knockout of TvAD1. CRISPR-directed knockout of TVAD1 was performed as
previously described (55) with modifications. For construction of the pCas9-2xgRNA construct targeting
the TvAD1 gene, each individual gRNA cassette containing the U6 seed region and gRNA scaffold was con-
structed by megaprimer amplification of the gRNA scaffold. The TvAD1 gRNA-1 was constructed using
primers 157gRNA1_for (59-GTCAAACATATTCTATTACATCATCAACACTCATTCTGTTTTAGAGCTAGAAATAGC-39)
and U6-KpnI_Rev (59-CTGCATGGTACCAAAAAATGGGACCTATCCAGA-39), and the resulting product was
purified and used in a second PCR with primer U6-SacI_For (59-ATCTGCGAGCTCATTAAGGGTGAA
TGGCTAC-39). For TvAD1 gRNA-2, the seed region was generated using primers 157gRNA2_for (59-
GTCAAACATATTCTATTACCCATTAAGACATCCTTTCGTTTTAGAGCTAGAAATAGC-39) and U6-SacI_Rev (59-
CTGCATGAGCTCAAAAAATGGGACCTATCCAGA-39), and its product was purified for use in a second PCR with
primer U6-KpnI_For (59-ATCTGCGGTACCATTAAGGGTGAATGGCTAC-39). The two TvAD1-gRNA PCR products
were digested with KpnI, ligated together, and purified. The resulting dual gRNA product was then digested
with SacI and ligated into a derivative of pMPAC::fkbp-cas9-gRNA (55) that harbors no selection marker
to create pMD::fkbp-cas9-gRNA(TvAD1). Construction of the TvAD1 KO cassette utilized 1,000 bp
upstream of the TvAD1 start codon (59 UTR) and 1,000 bp downstream of the stop codon (39 UTR). PCR
amplification of the 1,000-bp 59 UTR sequence utilized primers 5UTR-157_For (59-ATCTGCGGAT
CCACATGATTAATCAAAGCTATATCGATG-39) and 5UTR-157_Rev (59-CTGCATGGCGCGCCTAATAAAAATG
AAGAGATATTTAGC-39). PCR amplification of the 1,000-bp 39 UTR sequence utilized primers 3UTR-
157_For (59-ATCTGCGGTACCATAAAGTAAAAGATCTTTTTTTATGTAATTTTCACAG-39) and 3UTR_Rev (59-
CTGCATGAGCTCATATACCGAGATTTTTTTATCTATTTTCAG-39). The 59 UTR and 39 UTR sequences were
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ligated to the NeoR gene to create the TvAD1-KO cassette. Generation of the linearized KO cassette
was done using PCR and the 5UTR-157_For and 3UTR_Rev primers.
Knockout of the TvAD1 gene in the T. vaginalis LSU160 MA strain was done under nucleofection con-
ditions as previously described (55), except the X-001 and V-kit buffer (Lonza) were utilized along with
pMD::fkbp-cas9-gRNA (TvAD1) and 100mg of linearized TvAD1-KO cassette. Immediately following nucle-
ofection, parasites were recovered in completed Diamond’s media for 24 hours and then selected for re-
sistance to 100mg/ml of G418 (Gibco). After an additional 24 hours for selection, the MA parasites were
pelleted, resuspended in fresh complete Diamond’s media, and redosed with 100mg/ml G418. Drug-
selected parasites were then subpopulated into 5 cells/well in a 24-well plate. When the parasites
reached ;1 107 parasites/ml, genomic DNA was prepared for PCR screening. Initial screening was
done at the 59 UTR integration site using primer 5UTR_For (59-GAATTCCATGTTTCAGACTGCC-39) located
upstream of the 1,000-bp 59 UTR homology arm sequence and Neo_Rev (59-AGCCGATTGTCT
GTTGTGCCC-39). A subpopulation with the correct 59 UTR Neo integration was cloned via limiting dilu-
tion and rescreened for integration at the 59 UTR using the primers above as well as integration at the 39
UTR end using primers Neo_For (59-CGCTATCAGGACATAGCGTTGGC-39) and 3UTR_Rev (59-GATCTTAA
CTTTGGTTACATACAAGCTG-39), of which the latter is located downstream of the 1,000-bp 39 UTR homol-
ogy arm sequence. Screening for the wild-type TvAD1 gene used primers 5UTR_For and 157internal_Rev
(59-TCTGAGCAGCAGCACTTCTTG-39). All PCR products were confirmed by DNA sequencing.
Plasmid construction for TvAD1 exogenous expression in T. vaginalis parasites. For exogenous
expression of TvAD1 in poorly adherent T. vaginalis G3 parasites, TvAD1 was PCR amplified from LSU
160 MA genomic DNA using primers TvAD1_NdeI-For (59-CATATGTTTGGACTTCTTGGACTCTCA-39) and
TvAD1_Kpni-Rev (59-GGTACCTTATACCTTGTCTGAGCAGCAGC-39). The resulting PCR fragment was cloned
into the MasterNeo-(HA)2 plasmid (71). Nucleofection of the poorly adherent T. vaginalis G3 strain with
50mg pMNeo_TvAD1-2xHA or 50mg pMNeo_EV (empty vector) was done as described above except for
the use of T cell buffer(Lonza) and the U-033 nucleofection program. Transfectants were selected and
maintained using 100mg/ml G418. When the parasites reached ;1 107 parasites/ml, 5 106 parasites
were taken and lysed in lysis buffer (50mM Tris-HCl, 5mM EDTA, 150mM NaCl, 0.1% Nonidet P-40, 0.5%
deoxycholate, 2% SDS, and HALT protease inhibitor). Protein concentrations were quantified by
Bradford assay (Bio-Rad), and 10mg protein was used to confirm expression of exogenous TvAD1 by
anti-HA Western blot.
Plasmid construction for TvAD1 complementation in KO parasites was carried out in a similar fashion
with the following modifications. The pMNeo_TvAD1-2xHA plasmid was digested to replace the neomy-
cin phosphotransferase (neo) selectable marker with the puromycin N-acetyltransferase gene (72) as pre-
viously described (29) to generate pMPAC_TvAD1-2xHA. Nucleofection of the TvAD1-KO parasites with
50mg pMPAC_TvAD1-2xHA or 50mg pMPAC_EV was done as described above for the KO parasites, and
transfectants were selected and maintained using 60mg/ml puromycin dihydrochloride (A.G. Scientific,
Inc.). Exogenous protein expression was confirmed by anti-HA Western blot as described above.
Production and purification of rTvAD1. The TvAD1 protein without the C-terminal transmembrane
domain (missing residues 281 to 310) was PCR amplified from LSU 160 genomic DNA using the following
primer pair: SalI157-for (59-ATCTGCGTCGACATGTTTGGACTTCTTGGACTC-39) and NotI157-rev (59-ATC-
TGCGCGGCCGCAACCCAAGCCCAAACTGG-39). PCR amplicons were cloned into the pET28b(1) expres-
sion vector containing a 6-His tag and transformed into BL21(DE3) Escherichia coli (Thermo Scientific).
An overnight culture was inoculated into 1 liter LB medium supplemented with 100mg/ml ampicillin.
When the culture reached an optical density at 600 nm (OD600) of 0.5 to 0.6, expression was induced
with 1mM isopropyl b-D-1-thiogalactopyranoside (IPTG) for 5 h at 37°C. The culture was then spun at
5,000  g for 30min at 4°C, and the pellet was resuspended in 1 g/3ml lysis buffer (10mM Tris-HCl,
100mM NaCl, 8 M urea, and HALT protease inhibitor [pH 8]).
Lysates underwent 6 cycles of freeze-thaw lysis and then were centrifuged at 22,095 g for 2 h at
4°C. The clarified lysate was filtered using a 0.44-mm filter and diluted 1:3 using dilution buffer (10mM
Tris-HCl, 300mM NaCl, and 4 M urea [pH 8]). The denatured proteins were then purified by Ni-nitrilotri-
acetic acid (NTA) agarose (Qiagen) affinity chromatography. rTvAD1 purity following affinity chromatog-
raphy was confirmed by SDS-PAGE and Coomassie blue staining. Purified rTvAD1 was quantified by
Bradford assay, diluted to 100mg/ml using dilution buffer, and dialyzed in the same buffer overnight at
4°C to remove imidazole and reduce urea concentration to 4 M. Urea concentration was further reduced
in a stepwise reduction manner (73) by dialyzing against 20mM Tris-HCl [pH 8], 150mM NaCl, 0.2 M L-ar-
ginine (74), 10% glycerol, and decreasing concentrations of urea at every stage (3 M, 2 M, 1.5 M, 1 M, 0.5
M, and 0.25 M). In the final step, the protein was dialyzed against 20mM Tris-HCl [pH 8], 150mM NaCl,
50mM L-arginine, 50mM L-glutamic acid (75), and 10% glycerol. Each dialysis step was carried out for a
minimum of 5 h with a buffer change at 1.5 h and 3 h. Refolded protein was concentrated using sucrose
reverse dialysis (76), and concentration was determined by Bradford assay.
Intrinsic tryptophan fluorescence. Intrinsic tryptophan fluorescence spectra of refolded rTvAD1
was recorded using a PTI QuantaMaster spectrofluorometer (Horiba) upon excitation at 290 nm.
Tryptophan fluorescence emission spectra were recorded between 300 and 450 nm. The excitation and
emission slits were both set at 5 nm. Integration time was set at 10 sec. All experiments were performed
at 25°C using a protein concentration of 285.7 nM. The fluorescence emission spectra of refolded rTvAD1
without denaturant and under denaturing conditions (4 M and 8 M urea) were normalized to the
refolded rTvAD1 maximum fluorescence intensity following subtraction of the blank buffer emission
spectra values.
ITC analysis. Interaction of TvAD1 with heparan sulfate (HS) was monitored by isothermal titration
calorimetry (ITC)-based experiments using an iTC200 instrument (MicroCal/GE Healthcare, Piscataway,
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NJ). All the protein samples were dialyzed in a buffer containing 20mM Tris-HCl [pH 8], 150mM NaCl,
50mM L-arginine, 50mM L-glutamic acid, and 10% glycerol. For the ITC measurement, the sample cell
(cell volume of 0.250ml) was filled with rTvAD1 (146.2mM) and the reference cell was filled with same
buffer in which the protein was dialyzed. rTvAD1 was titrated with HS using the following protocol: an
initial 0.2-ml injection followed by 19 injections of 2ml each with an interval of 3min and under constant
stirring at 750 rpm at 25°C. The binding isotherm profile was obtained omitting the initial data point.
The data were fitted using Origin 7 software. The dissociation constant (Kd) was determined from 1/Ka
where Ka is the binding constant.
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